TK1 activity may be influenced by certain chemotherapeutic agents both by interference with the synthesis of deoxy-thymidine-mono-phosphate [19–21], with a compensative increase of TK1 expression, or as a measure of increased cell proliferation in the bone-marrow, after chemotherapeutic induced leukopenia [16]. Here, TK1 is linked to Decreased total leukocyte count.